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Background: Data on head and neck cancers is scarce in the developing countries including Africa. These 
cancers are more common in the Western countries. In the USA for instance, over 50,000 new cases occur 
annually. Head and neck cancers subtypes include oral cancers, oral pharyngeal cancers, larynx and 
nasopharyngeal cancers. Some of the associated causes of head and neck cancers include oncogenic viruses, 
irradiation, dietary factors and genetic predisposition. These cancers present a major challenge in their 
management due to their occurrence near vital structures of the head and neck region. Diagnosis or screening is 
difficult in the early stages due to the hidden nature of the lesions often resulting in late clinical presentation. 
Treatment modalities include surgery, radiotherapy and chemotherapy alone or in combination. 
 Study Design: This was a retrospective study. 
Materials and Methods: We reviewed data from the population based Nairobi Cancer Registry (NCR) for the 
occurrence of Head and Neck Cancers (HNC’s)  in relation to the frequencies of all cancers registered within the 
period between 2000-2003. We also determined the demographical, clinical and the histological features of these 
cancers. 
 Results: For the period 2000-2003, head and neck cancers comprised over 12.8% (697) of all the 5462 cancers 
reported from all cancer sites with a male to female ratio of 2:1. Among the head and neck sub-sites, oral 
cancers were the highest at 40.6%, followed by nasopharynx and laryngeal cancers with 20.8% and 13.8 % 
respectively. The commonest histology was squamous cell carcinoma. 
Conclusion:According to the cancer cases registered with the Nairobi Cancer Registry within the analysed 
period, Head and neck cancers comprised of a significant problem of all the cancers. They are characterised by 
high rates of oral and nasopharyngeal cancers. 
 
 
[Afr J Health Sci. 2011; 19:30-35]
 
Introduction 
Head and neck cancers(HNCs) occur in various 
anatomical subsites within the head and neck region 
and are classified into several subtypes including oral 
and oral pharyngeal cancers, larynx and 
nasopharyngeal cancers (1,2). Various factors have 
been reported as risk factors for the HNCs. These 
include alcohol intake ,cigarette smoking, irradiation, 
oncogenic virus infections like Epstein Barr virus 
(EBV) and Human Papilloma Virus (HPV). EBV is 
commonly associated with nasopharyngeal carcinoma 
and HPV has been associated with laryngeal 
carcinoma. Human immnodefficiency virus (HIV) on 
the other hand is associated with Kaposi’s Sarcoma 
(KS) (2,7). Oral and oral pharyngeal cancers have been 
in particular associated with use of spices, betel nuts, 
recurrent oral inflammations and HPV (13). Head and 
neck cancers present a challenge due to their 
occurrence near vital head and neck structures.  
Difficult deglutition, breathing and obstructive 
swellings are therefore common presentations. Indeed, 
most of these HNC’S present late due to the hidden 
nature of their site of occurrence thereby making 
screening or early diagnosis for these cancers difficult. 
Oral cancers however are an exception since the oral 
cavity is very accessible. The treatment of these 
tumours remains a challenge due to late presentation. 
Surgery remains the mainstay of treatment for early 
operable cancers, followed by adjuvant radiotherapy 
for persistent and recurrent tumours. However, despite 
advances in medical knowledge, survival rates have not 
improved. Data on head and neck cancers is scarce in 
the developing countries including Africa. These 
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cancers are more common in the Western countries 
(1,10). In the USA for instance, over 50,000 new cases 
occur annually. Reliable data from Africa is absent and 
most of the data are from hospital-based registries or 
case series as opposed to the gold standard of 
population -based registries (10). The Nairobi Cancer 
registry was started in the year 2000 as a population-
based registry to fill this gap in cancer registration by 
collecting cancer data from a defined population. 
 
Methodology 
This was a retrospective study based at the registry. 
The Nairobi Cancer registry data collection is ongoing 
from year 2000. It covers Nairobi city and its 
surrounding with an estimated population of 3.5 
million. The active collection data is conducted at 
various healthcare facilities that are registered with the 
registry. These facilities allow active collection of the 
data by the registry staff voluntarily. Data are also 
collected from the registry of deaths simultaneously 
.This death register therefore provides the mortality 
status of the registered cancer cases.  
The Nairobi Cancer registry uses a special proforma 
that captures the demographic features, the clinical 
stage, basis of diagnosis and the status of the cancer 
cases. The data collected is for all types of cancers and 
follows the WHO International Coding protocol for 
diseases (ICD-10). 
Once the data is collected, its entered into the registry’s 
data computer base using the Can Reg4 
software.CanReg4 software is a special standard 
software used by all cancer registries under the 
auspices of the International cancer registries 
association (IACR) of which the NCR is a member. 
This assists in standardisation and allows for data 
comparison between the member organisations. This 
software is provided under WHO by the International 
Agency for Research against Cancer (IARC). CanReg4 
software avoids double entries for patients who would 
have sought care from more than one healthcare 
facilities where data is collected from. 
In this study we sought to find the demographic, 
clinical status, histology and sites of occurrence of 
head and neck cancers. 
From this database, we proceeded to extract data on 
head and neck cancers and using MS-excel worked out 
the relevant statistics for the study.  
 
Results 
During the period 2000-2003 a total of 697 head and 
neck cancers were recorded out of a total of 5462 cases 
from all cancer sites. This comprised of 12.8 % of the 
total cases. The male: female ratio was 2:1 
(male:17.6% and female: 7.2%) . These cases were 
seen at various healthcare centers in Nairobi area. 
 




Cases Percentage. (%) 
ACACIA LABORATORY 1 0.1% 
ARMED FORCES MEMORIAL 5 0.7% 
AVENUE NURSING HOME 10 1.4% 
COPTIC CHURCH NURSING  1 0.1% 
DEATH CERTIFICATE ONLY 52 7.5% 
EQUATOR NURSING HOME 13 1.9% 
KENYA MEDICAL RESEARCH 1 0.1% 
KENYATTA NATIONAL HOSPITAL 261 37.4% 
M.P. SHAH HOSPITAL 10 1.4% 
MATER MISERICODIAE HOSPITAL 11 1.6% 
MBAGATHI DISTRICT HOSPITAL 4 0.6% 
MEDICAL IMAGING & THERAPEUTIC  CENTRE 20 2.9% 
NAIROBI HOSPICE 133 19.1% 
THE PATHOLOGY CLINIC 6 0.9% 
NAIROBI PATHOLOGY SERVICES 3 0.4% 
NAIROBI WEST HOSPITAL 3 0.4% 
NAIROBI WOMENS HOSPITAL 1 0.1% 
SOUTH B. NURSING HOME 3 0.4% 
THE AGA KHAN HOSPITAL,NAIROBI 23 3.3% 
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THE NAIROBI HOSPITAL 54 7.7% 
UON - DENTAL SCHOOL 82 11.8% 
Grand Total 697 100.0% 
 
A substantial number of cases were seen at Kenyatta 
National Hospital 261 (37.4%) followed by Nairobi 
Hospice 133 (19.1%), U.O.N Dental school 82 
(11.8%). This may be attributed to the fact that they are 
referral points for other smaller hospitals offering 
various oncological services. 
The percentage indicated for each data collection site 
does not include those patients that sought care from 
more than one centre but only from that site alone. 
 
 
Figure 1: Head & Neck Cancers by age-group 
 
















































































It is noted that the 50-54 years was the most affected age-group followed by the 60-64 years age group. 
 
Figure 2: Analysis of cases by place of Birth 
































































From the data above Central and Eastern provinces had 
the highest cases at 27.5% and 18.75% respectively 
(figure 3). Unknown denotes cases whose origin could 
not be determined. 
 
FIGURE 3 :  Head and Neck cancers by specific sites of occurrence  
































































The data showed that oral cancers at 40.6% were leading followed by nasopharynx  at  20.8% and then nasopharyngeal 
cancers at 13.8%.ORAL: includes, floor of the mouth, alveolus (GUM), lip,palate and tongue proper. 
OROPHARYNX : include pharynx, tonsils ,tongue base. 
 
Table 3: Common Histologies of Head and Neck cancers 
Squamous cell carcinoma    37.3% 
Carcinoma, NOS (not otherwise 
specified) 
19.7% 
Anaplastic carcinoma 10.2% 
Kaposi sarcoma  5.1% 
Adenocarcinoma 2.9% 
Adenocystic carcinoma   2.9% 
Others 21.9% 
 
The commonest overall histological type of cancer is squamous cell carcinoma. 
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Discussion 
Collection of data for the registry involved several 
locations (Table 1) but this was not exhaustive. Several 
healthcare centers declined to participate in this ongoing 
process. This was because there is no policy obligation 
for healthcare sites to issue data to the registry. This 
therefore could have limited the numbers from Nairobi, 
obscuring the true burden of cancer. 
The findings of this study shows showed 697 cases 
recorded in four-year period compared with a study in 
Jos, Nigeria for 15 years recorded 710 cases (6), and in 
Ife city they found 313 cases during a ten-year period 
(7). A recent study hospital study in Nairobi found 793 
cases during a two-year period. However, these patients 
were from all over the country and not just Nairobi (8). 
 The head and neck cancers were more common in the 
males than females at a ratio of 2:1. This has also been 
found in other reports locally and in other countries 
(2,3,6,7,8). In the USA the male to female ratio was 
2.3:1 with the incidence reported to increase with age 
(9, 11). In Nairobi, it was noted that the 50-54 years age 
group was the most affected followed by 60-64 year age 
group (Figure 1). Ologe in Ilorin Nigeria found a peak 
age in fifth decade (7).These ages are comparatively 
lower than those of the West with the peaks late by one 
to two decades. In other words, the cancers are 
occurring in comparatively younger people in our 
African setup. 
In terms of the residence, most of the patients came 
from Nairobi followed by Central and Eastern 
provinces. However, when the data was analyzed by 
place of birth the majority of patients were found to be 
from Central and Eastern provinces at 27.5% and 
18.75% respectively. Very few were born in Nairobi 
area itself. It was not deducible from this study why 
most patients were from Central and Eastern provinces 
other than the provinces’ proximity to Nairobi. 
However, a large figure of unknown residence or 
birthplace was due to unavailable records. This was 
repeated in other parameters like clinical staging. From 
the data, most hospital records indicated only late 
clinical stage IV at a mere 2%, the majority of the 
tumours (98%) having not been  staged at all. Poor 
record keeping and lack of proper staging has been 
reminiscent in many developing countries (2,6,7,10). 
The majority of head and neck cancer subgroup 
corresponding to the various sub-sites were oral cancers 
at 40.6% followed by cancers of the nasopharynx at 
20.8% and then larynx. This differs from other studies 
in Kenya in which laryngeal cancer was found to be the 
leading head and neck cancer (8). This difference may 
be because the Nairobi Cancer registry is population-
based and not hospital-based registry.  A survey of the 
national data in the USA found incidences of  oral 
cancers at 40%, laryngeal cancer at 25%  and 
Nasopharyngeal carcinoma (NPC) was at 20.8% (11). 
Trends in Kenya tend to be similar in oral and laryngeal 
cancers in with the USA but are comparatively higher 
for NPC locally compared with USA and relatively 
moderate compared to China (9,11). 
Whereas, the high incidence of oral cancers  in the USA 
and other western countries  is associated with  human 
papilloma virus infections, it is difficult to tell this from 
our set up at this stage since no epidemiological or 
molecular studies have been done on oral cancers and 
HPV. Otoh et al in Nigeria found similar trends 
reporting the most common cancer sites as oral cancers 
at 15.1% and nasopharyngeal cancers at 11.7%. 
However, their numbers were comparatively lower than 
in Nairobi probably because theirs was a hospital-based 
registry study (6).  
The microscopic verification (M/V) ratio in this study 
was found to be over 80%. This is higher than expected 
for population-based registries in the developing world 
(1,10).The reason could be that  most of the patients 
with head and neck cancers in the whole country 
eventually get treated in Nairobi hence the M/V ratio 
approximates that of a hospital registry. Increased case 
finding from the smallest health unit will increase the 
absolute numbers and thus would lower the M/V ratio to 
acceptable level.  
In this study squamous cell carcinoma remained the 
leading histological type across the cancer types varying 
from 70% to over 90 % of all cancers. This is also the 
predominant histology in head and neck cancers 
worldwide (1, 3, 6, 7). This was followed by anaplastic 
carcinomas, which are common in the nasopharyngeal 
tumours (Table 3). It was however a rare histology in 
laryngeal cancers or oral cancers. Adenocarcinomas and 
adenocystic carcinomas were uncommon in all the sites 
and overall in  head and neck cancers. This trend is 
similar in the USA, where over eight sites had 
predominantly squamous cell carcinoma including 
larynx and oral pharyngeal tumours at more than 90% 
(9,11 ).  
One of the salient and challenging out come of this 
analysis is the poor levels of staging for cancer. Most of 
the cancers were poorly staged or the records could not 
be verified. However, since the records indicated only 
the clinical staging or TNM (Tumour, Node, and 
Metastasis) system, it was possible that most of the 
unknown were merely late presentations and therefore 
either at stages three or four.  
However, the unusually large percentage of head and 
neck cancers with no clinical stage indicated in the 
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healthcare records (60%) calls for urgent remedial action by all concerned parties.  
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